ACM Research (ACMR) Financials

$20.50 +0.34 (+1.69%)

Closing price 04/15/2025 04:00 PM Eastern

Extended Trading

$20.38 -0.13 (-0.61%)

As of 04/15/2025 07:49 PM Eastern

Annual Income Statements for ACM Research

This table shows ACM Research's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	1.03	-0.32	6.57	19	19	38	39	77	104
Consolidated Net Income / (Loss)	2.39	-0.87	6.57	19	22	43	51	97	131
Net Income / (Loss) Continuing Operations	2.39	-0.87	6.57	19	22	43	51	97	131
Total Pre-Tax Income	2.98	-0.33	7.38	19	19	43	67	116	166
Total Operating Income	3.49	0.70	6.47	18	21	39	59	96	151
Total Gross Profit	13	17	34	51	70	115	184	276	392
Total Revenue	27	37	75	108	157	260	389	558	782
Operating Revenue	27	37	75	108	157	260	389	558	782
Total Cost of Revenue	14	19	40	57	87	145	205	282	391
Operating Cost of Revenue	14	19	40	57	87	145	205	282	391
Total Operating Expenses	9.84	17	28	33	48	76	125	180	241
Selling, General & Admin Expense	2.67	5.89	7.99	8.06	12	15	22	41	70
Marketing Expense	3.91	5.50	9.61	12	17	27	40	47	65
Research & Development Expense	3.26	5.14	10	13	19	34	62	93	105
Total Other Income / (Expense), net	-0.51	-1.03	0.91	1.15	-2.20	4.35	8.33	20	15
Interest Expense	0.52	1.07	0.50	0.75	0.98	0.77	1.66	2.68	4.15
Interest & Investment Income	0.02	0.05	0.15	0.50	1.55	5.14	13	18	10
Other Income / (Expense), net	-	-	1.26	1.39	-2.77	-0.02	-3.42	4.75	9.10
Income Tax Expense	0.60	0.55	0.81	-0.52	-2.38	0.13	17	19	35
Net Income / (Loss) Attributable to Noncontrolling Interest	1.36	-0.55	0.00	0.56	2.90	5.16	11	20	28
Basic Earnings per Share	$0.30	($0.05)	$0.42	$1.12	$0.34	$0.65	$0.66	$1.29	$1.67
Weighted Average Basic Shares Outstanding	2.18M	6.87M	15.79M	16.80M	54.70M	57.65M	59.24M	60.16M	62.21M
Diluted Earnings per Share	$0.18	($0.05)	$0.37	$0.99	$0.30	$0.58	$0.59	$1.16	$1.53
Weighted Average Diluted Shares Outstanding	3.79M	6.87M	17.91M	19.14M	63.55M	65.36M	65.34M	64.87M	66.24M
Weighted Average Basic & Diluted Shares Outstanding	-	12.99M	15.70M	18.14M	18.74M	19.58M	59.70M	61.10M	63.13M

This table shows ACM Research's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	21	12	7.15	27	26	18	17	24	31	31
Consolidated Net Income / (Loss)	27	14	8.96	34	31	23	22	31	39	39
Net Income / (Loss) Continuing Operations	27	14	8.96	34	31	23	22	31	39	39
Total Pre-Tax Income	38	17	12	41	32	31	26	41	43	56
Total Operating Income	32	17	8.86	30	33	23	25	38	44	44
Total Gross Profit	66	54	40	69	89	79	79	97	105	111
Total Revenue	134	109	74	145	169	170	152	202	204	223
Operating Revenue	134	109	74	145	169	170	152	202	204	223
Total Cost of Revenue	68	55	34	76	80	91	73	106	99	113
Operating Cost of Revenue	68	55	34	76	80	91	73	106	99	113
Total Operating Expenses	34	37	31	38	55	56	54	59	61	67
Selling, General & Admin Expense	5.52	6.91	7.76	6.71	12	14	16	16	17	21
Marketing Expense	13	12	9.34	11	17	9.44	14	17	16	18
Research & Development Expense	16	18	14	20	26	32	24	26	28	28
Total Other Income / (Expense), net	5.91	0.17	2.98	11	-1.46	8.05	1.23	3.14	-1.51	12
Interest Expense	0.42	0.67	0.70	0.65	0.64	0.70	0.78	0.93	1.21	1.23
Interest & Investment Income	3.27	5.79	1.75	6.27	1.99	8.30	1.25	1.69	4.28	3.14
Other Income / (Expense), net	3.06	-4.95	1.92	5.19	-2.81	0.46	0.76	2.39	-4.58	11
Income Tax Expense	10	2.66	2.88	7.64	0.72	8.13	4.37	9.34	4.01	17
Net Income / (Loss) Attributable to Noncontrolling Interest	6.07	2.37	1.82	6.77	5.32	5.60	4.66	7.19	7.77	8.03
Basic Earnings per Share	$0.35	$0.20	$0.12	$0.45	$0.43	$0.29	$0.28	$0.39	$0.49	$0.51
Weighted Average Basic Shares Outstanding	59.36M	59.24M	59.74M	59.90M	60.22M	60.16M	61.37M	62.18M	62.50M	62.21M
Diluted Earnings per Share	$0.32	$0.20	$0.11	$0.41	$0.39	$0.29	$0.26	$0.35	$0.45	$0.47
Weighted Average Diluted Shares Outstanding	65.61M	65.34M	65.06M	64.93M	65.45M	64.87M	66.24M	67.06M	66.67M	66.24M
Weighted Average Basic & Diluted Shares Outstanding	59.46M	59.70M	59.87M	60.02M	60.61M	61.10M	62.01M	62.47M	62.63M	63.13M

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	5.72	7.56	9.96	91	-46	491	-315	-65	228
Net Cash From Operating Activities	-7.35	-8.10	6.91	9.40	-14	-40	-62	-75	152
Net Cash From Continuing Operating Activities	-3.70	-8.10	6.91	9.40	-14	-40	-62	-75	152
Net Income / (Loss) Continuing Operations	2.39	-0.87	6.57	19	22	43	51	97	131
Consolidated Net Income / (Loss)	-2.39	-0.87	6.57	19	22	43	51	97	131
Depreciation Expense	0.19	0.27	0.42	0.79	1.06	2.35	5.37	8.09	9.97
Non-Cash Adjustments To Reconcile Net Income	-1.99	1.59	3.24	4.40	-0.26	37	118	49	137
Changes in Operating Assets and Liabilities, net	0.49	-9.09	-3.32	-15	-36	-123	-236	-229	-126
Net Cash From Investing Activities	-0.81	-24	-2.07	-5.53	-70	-11	-266	-6.75	-12
Net Cash From Continuing Investing Activities	-0.81	-24	-2.07	-5.53	-70	-11	-266	-6.75	-12
Purchase of Property, Plant & Equipment	-0.80	-0.65	-1.83	-0.97	-5.21	-9.15	-91	-62	-82
Acquisitions	-0.02	-1.32	-0.24	-0.15	-0.32	-0.56	-1.43	-2.46	-3.49
Purchase of Investments	0.00	-0.95	0.00	-4.41	-15	-1.57	-5.28	-26	-26
Sale and/or Maturity of Investments	-	-	0.00	0.00	0.56	0.00	4.58	110	175
Other Investing Activities, net	0.00	-21	0.00	0.00	-50	0.00	-172	-26	-75
Net Cash From Financing Activities	11	39	5.12	87	33	539	46	19	92
Net Cash From Continuing Financing Activities	11	39	5.12	87	33	539	46	19	92
Repayment of Debt	-7.72	-11	-13	-14	-22	-42	-11	-57	-42
Payment of Dividends	-	-	-	-	-	-	0.00	-3.95	-6.90
Issuance of Debt	5.92	11	18	18	52	30	56	74	130
Other Financing Activities, net	3.31	-0.14	0.53	-0.26	2.75	5.25	1.31	6.14	11
Effect of Exchange Rate Changes	-0.32	0.66	-	-0.58	4.57	3.91	-33	-1.74	-4.84
Cash Interest Paid	0.18	0.28	0.50	0.75	0.98	0.77	1.66	2.68	4.15
Cash Income Taxes Paid	-	-	0.00	1.16	4.97	1.13	3.59	26	11

This table details how cash moves in and out of ACM Research's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	12	-88	12	-2.85	-50	-24	29	113	10	76
Net Cash From Operating Activities	-0.10	-0.80	-30	11	-18	-38	-9.65	62	12	89
Net Cash From Continuing Operating Activities	-0.10	-0.80	-30	11	-18	-38	-9.65	62	12	89
Net Income / (Loss) Continuing Operations	27	14	8.96	34	31	23	22	31	39	39
Consolidated Net Income / (Loss)	27	14	8.96	34	31	23	22	31	39	39
Depreciation Expense	1.55	1.26	1.71	2.24	2.07	2.07	2.52	2.17	2.39	2.89
Non-Cash Adjustments To Reconcile Net Income	53	13	26	29	11	-17	23	42	24	48
Changes in Operating Assets and Liabilities, net	-82	-30	-67	-54	-62	-47	-57	-14	-54	-1.41
Net Cash From Investing Activities	-8.67	-107	49	-7.58	-49	0.54	12	20	-23	-21
Net Cash From Continuing Investing Activities	-8.67	-107	49	-7.58	-49	0.54	12	20	-23	-21
Purchase of Property, Plant & Equipment	-15	-71	-15	-6.74	-28	-12	-25	-13	-33	-11
Acquisitions	-0.63	-0.35	-0.16	-1.13	-0.33	-0.85	-0.67	-0.48	-0.83	-1.50
Purchase of Investments	-	-0.08	-0.73	-0.73	-23	-1.27	-7.40	-1.37	-	-17
Sale and/or Maturity of Investments	4.49	0.09	79	0.73	12	18	91	47	21	16
Other Investing Activities, net	7.95	-36	-14	0.28	-9.09	-3.19	-45	-13	-11	-5.92
Net Cash From Financing Activities	41	9.44	-1.46	4.87	3.60	12	27	31	19	15
Net Cash From Continuing Financing Activities	41	9.44	-1.46	4.87	3.60	12	27	31	19	15
Repayment of Debt	-9.68	3.96	-1.70	0.59	-50	-5.85	-1.48	-2.92	-33	-4.84
Issuance of Debt	-	5.32	0.00	-	57	17	24	33	58	16
Other Financing Activities, net	0.40	0.16	0.24	4.28	0.77	0.85	4.80	1.64	0.05	4.61
Effect of Exchange Rate Changes	-20	9.93	-4.78	-11	13	1.81	-0.55	0.21	2.97	-7.46
Cash Interest Paid	0.42	0.67	0.70	0.65	0.64	0.70	0.78	0.93	1.21	1.23
Cash Income Taxes Paid	0.06	3.40	2.87	4.37	9.23	9.63	0.00	9.11	0.69	1.42

This table presents ACM Research's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	44	68	103	218	341	1,052	1,236	1,491	1,856
Total Current Assets	40	63	96	198	261	953	964	1,176	1,483
Cash & Equivalents	10	18	27	58	72	563	248	182	407
Restricted Cash	-	-	0.00	60	-	0.52	0.50	1.08	3.87
Short-Term Investments	-	-	-	0.00	28	29	20	21	19
Accounts Receivable	18	29	28	34	66	125	216	326	430
Inventories, net	12	15	39	45	89	218	393	545	598
Prepaid Expenses	0.72	0.55	1.99	2.05	5.89	14	16	20	7.51
Other Current Assets	0.05	0.05	-	-	-	2.38	70	81	17
Plant, Property, & Equipment, net	2.26	2.34	3.71	3.62	8.19	14	83	202	269
Total Noncurrent Assets	1.86	2.64	3.31	16	72	85	189	113	103
Long-Term Investments	0.00	1.24	1.36	5.93	6.34	13	17	28	37
Intangible Assets	0.02	0.11	0.27	0.34	0.55	0.48	1.26	2.54	3.46
Noncurrent Deferred & Refundable Income Taxes	1.84	1.29	1.64	5.33	11	13	6.70	20	15
Other Noncurrent Operating Assets	-	0.00	0.04	4.08	54	59	163	62	48
Total Liabilities & Shareholders' Equity	44	68	103	218	341	1,052	1,236	1,491	1,856
Total Liabilities	24	28	51	60	133	241	423	565	760
Total Current Liabilities	17	22	46	54	103	206	396	501	641
Short-Term Debt	4.77	5.10	9.45	14	28	12	58	38	77
Accounts Payable	9.14	13	27	26	54	133	168	256	277
Current Deferred Revenue	0.22	0.14	-	9.13	1.34	56	158	185	252
Current Deferred & Payable Income Tax Liabilities	0.04	0.04	1.19	3.13	0.03	0.25	3.47	6.40	13
Other Current Liabilities	0.00	3.08	8.42	1.36	19	4.60	8.07	15	22
Total Noncurrent Liabilities	6.88	6.22	4.58	6.72	30	35	27	64	119
Long-Term Debt	-	-	-	0.00	18	23	19	54	106
Other Noncurrent Operating Liabilities	6.88	6.22	4.58	6.72	11	10	8.43	10	13
Commitments & Contingencies	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2.49	40	52	97	208	812	812	926	1,096
Total Preferred & Common Equity	-2.43	40	52	97	141	676	675	767	905
Total Common Equity	-2.44	40	52	97	141	676	675	767	905
Common Stock	7.62	50	57	83	102	595	604	630	677
Retained Earnings	-9.64	-9.96	-3.39	16	34	64	94	157	260
Accumulated Other Comprehensive Income / (Loss)	-0.41	0.12	-0.86	-1.68	4.86	9.11	-41	-49	-63
Other Equity Adjustments	-	-	-	-	-	8.31	17	30	31
Noncontrolling Interest	4.92	-	-	0.00	67	135	137	159	191

This table presents ACM Research's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,148	1,313	1,317	1,410	1,557	1,668	1,794
Total Current Assets	971	994	997	1,116	1,229	1,343	1,445
Cash & Equivalents	336	260	257	207	211	324	333
Restricted Cash	0.37	0.46	0.58	0.56	0.81	0.88	1.78
Short-Term Investments	14	13	6.38	22	19	20	20
Accounts Receivable	203	222	236	286	349	350	430
Inventories, net	328	473	471	507	581	603	629
Prepaid Expenses	18	19	19	18	20	19	11
Other Current Assets	71	5.31	6.00	76	48	27	20
Plant, Property, & Equipment, net	66	150	159	191	219	229	250
Total Noncurrent Assets	110	169	161	103	109	96	99
Long-Term Investments	19	17	16	22	31	32	34
Intangible Assets	0.87	1.23	2.11	2.16	2.80	2.84	2.84
Noncurrent Deferred & Refundable Income Taxes	6.58	13	11	16	21	21	13
Other Noncurrent Operating Assets	84	138	132	63	53	40	49
Total Liabilities & Shareholders' Equity	1,148	1,313	1,317	1,410	1,557	1,668	1,794
Total Liabilities	374	480	484	532	596	666	725
Total Current Liabilities	346	450	456	482	533	586	610
Short-Term Debt	53	59	57	41	61	74	64
Accounts Payable	139	188	179	225	259	275	302
Current Deferred Revenue	142	185	201	196	187	211	226
Current Deferred & Payable Income Tax Liabilities	8.56	8.58	10	11	11	11	6.80
Other Current Liabilities	3.37	9.79	9.49	9.36	15	15	11
Total Noncurrent Liabilities	28	30	27	50	63	80	115
Long-Term Debt	19	18	16	40	53	71	106
Other Noncurrent Operating Liabilities	7.99	12	11	10	9.30	9.18	8.99
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	774	833	833	878	961	1,001	1,069
Total Preferred & Common Equity	643	692	692	729	796	833	888
Total Common Equity	643	692	692	729	796	833	888
Common Stock	601	606	613	620	647	659	670
Retained Earnings	91	101	124	152	174	198	229
Accumulated Other Comprehensive Income / (Loss)	-58	-33	-62	-60	-55	-55	-41
Other Equity Adjustments	8.31	17	17	17	30	30	30
Noncontrolling Interest	131	141	141	149	165	168	181

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	33.37%	104.47%	44.05%	45.66%	65.84%	49.69%	43.44%	40.23%
EBITDA Growth	0.00%	-73.59%	738.62%	145.27%	-0.96%	107.44%	48.61%	78.24%	56.47%
EBIT Growth	0.00%	-79.94%	1,003.71%	148.30%	-2.39%	106.56%	43.78%	80.88%	59.15%
NOPAT Growth	0.00%	-82.46%	1,076.38%	217.08%	32.10%	59.79%	14.86%	80.24%	49.23%
Net Income Growth	0.00%	-136.53%	853.90%	195.98%	11.40%	98.00%	17.81%	91.54%	35.54%
EPS Growth	0.00%	-127.78%	840.00%	167.57%	11.40%	98.00%	1.72%	96.61%	31.90%
Operating Cash Flow Growth	0.00%	-10.16%	185.29%	36.10%	-244.07%	-195.95%	-55.12%	-21.11%	302.40%
Free Cash Flow Firm Growth	0.00%	0.00%	85.65%	376.85%	-1,942.83%	27.27%	-474.56%	67.57%	191.41%
Invested Capital Growth	0.00%	71.59%	27.86%	42.53%	210.99%	63.59%	149.86%	30.31%	3.19%
Revenue Q/Q Growth	0.00%	0.00%	5.15%	3.62%	15.44%	23.59%	3.57%	12.46%	7.29%
EBITDA Q/Q Growth	0.00%	0.00%	0.98%	3.06%	21.96%	40.61%	-8.60%	13.49%	22.74%
EBIT Q/Q Growth	0.00%	0.00%	1.71%	2.28%	22.84%	41.67%	-10.10%	13.68%	23.72%
NOPAT Q/Q Growth	0.00%	0.00%	-16.95%	15.42%	15.69%	27.48%	-5.27%	3.80%	11.88%
Net Income Q/Q Growth	0.00%	0.00%	-14.10%	10.92%	29.96%	28.11%	-8.06%	10.39%	13.69%
EPS Q/Q Growth	0.00%	0.00%	-58.43%	-1.98%	29.96%	28.11%	-18.06%	-2.52%	6.25%
Operating Cash Flow Q/Q Growth	0.00%	42.62%	198.15%	92.29%	-321.39%	-329.58%	36.32%	-99.44%	497.80%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	113.29%	-1,768.86%	-1.05%	-31.23%	32.83%	353.48%
Invested Capital Q/Q Growth	0.00%	0.00%	-16.33%	-45.24%	43.31%	28.46%	26.56%	11.20%	-4.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-
Gross Margin	48.70%	47.18%	46.15%	47.11%	44.44%	44.22%	47.22%	49.53%	50.06%
EBITDA Margin	13.43%	2.66%	10.91%	18.57%	12.63%	15.80%	15.68%	19.49%	21.74%
Operating Margin	12.75%	1.92%	8.67%	16.55%	13.72%	14.90%	15.18%	17.18%	19.31%
EBIT Margin	12.75%	1.92%	10.35%	17.84%	11.96%	14.89%	14.30%	18.04%	20.47%
Profit (Net Income) Margin	8.72%	-2.39%	8.81%	18.10%	13.84%	16.52%	13.00%	17.37%	16.78%
Tax Burden Percent	80.05%	268.31%	89.08%	102.74%	112.35%	99.69%	75.06%	83.34%	78.94%
Interest Burden Percent	85.44%	-46.43%	95.52%	98.73%	103.04%	111.32%	121.13%	115.53%	103.88%
Effective Tax Rate	19.95%	0.00%	10.92%	-2.74%	-12.35%	0.31%	24.94%	16.66%	21.06%
Return on Invested Capital (ROIC)	18.41%	2.38%	19.43%	45.28%	24.77%	19.84%	10.50%	11.50%	14.93%
ROIC Less NNEP Spread (ROIC-NNEP)	26.02%	16.59%	14.51%	43.45%	27.66%	18.47%	8.89%	1.78%	9.25%
Return on Net Nonoperating Assets (RNNOA)	-6.78%	-5.27%	-5.17%	-26.73%	-12.91%	-11.42%	-4.27%	-0.36%	-1.94%
Return on Equity (ROE)	11.63%	-2.89%	14.26%	18.55%	11.86%	8.42%	6.23%	11.14%	12.98%
Cash Return on Invested Capital (CROIC)	0.00%	-50.34%	-5.02%	10.21%	-77.91%	-28.41%	-75.17%	-14.82%	11.78%
Operating Return on Assets (OROA)	7.85%	1.25%	9.04%	11.96%	6.70%	5.55%	4.86%	7.38%	9.57%
Return on Assets (ROA)	5.37%	-1.55%	7.69%	12.13%	7.76%	6.16%	4.42%	7.10%	7.84%
Return on Common Equity (ROCE)	-1.38%	-1.79%	14.26%	13.23%	7.73%	6.75%	5.18%	9.25%	10.74%
Return on Equity Simple (ROE_SIMPLE)	-98.07%	-2.19%	12.56%	19.99%	15.36%	6.35%	7.49%	12.62%	14.51%
Net Operating Profit after Tax (NOPAT)	2.79	0.49	5.76	18	24	39	44	80	119
NOPAT Margin	10.21%	1.34%	7.72%	17.00%	15.42%	14.85%	11.40%	14.32%	15.24%
Net Nonoperating Expense Percent (NNEP)	-7.61%	-14.21%	4.93%	1.83%	-2.89%	1.38%	1.60%	9.72%	5.68%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	4.98%	7.84%	9.32%
Cost of Revenue to Revenue	51.30%	52.82%	53.85%	52.89%	55.56%	55.78%	52.78%	50.47%	49.94%
SG&A Expenses to Revenue	9.77%	16.13%	10.70%	7.50%	7.80%	5.86%	5.78%	7.29%	8.90%
R&D to Revenue	11.91%	14.07%	13.91%	12.00%	12.21%	13.17%	16.00%	16.62%	13.49%
Operating Expenses to Revenue	35.95%	45.27%	37.48%	30.56%	30.72%	29.32%	32.04%	32.34%	30.76%
Earnings before Interest and Taxes (EBIT)	3.49	0.70	7.73	19	19	39	56	101	160
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	3.68	0.97	8.14	20	20	41	61	109	170
Valuation Ratios	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	2.02	3.33	3.45	10.63	2.46	0.68	1.54	1.05
Price to Tangible Book Value (P/TBV)	0.00	2.03	3.35	3.46	10.67	2.46	0.68	1.55	1.05
Price to Revenue (P/Rev)	0.00	2.21	2.33	3.12	9.58	6.40	1.18	2.12	1.21
Price to Earnings (P/E)	0.00	0.00	26.49	17.77	79.89	44.06	11.68	15.31	9.13
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	3.78%	5.63%	1.25%	2.27%	8.56%	6.53%	10.96%
Enterprise Value to Invested Capital (EV/IC)	0.00	2.56	4.66	6.03	10.21	5.09	0.64	1.53	1.05
Enterprise Value to Revenue (EV/Rev)	0.00	1.83	2.08	2.66	9.62	4.73	0.99	2.16	1.09
Enterprise Value to EBITDA (EV/EBITDA)	0.00	68.73	19.05	14.31	76.17	29.94	6.34	11.07	5.01
Enterprise Value to EBIT (EV/EBIT)	0.00	95.34	20.07	14.90	80.46	31.76	6.95	11.96	5.32
Enterprise Value to NOPAT (EV/NOPAT)	0.00	136.20	26.90	15.64	62.40	31.84	8.73	15.06	7.15
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	22.45	30.40	0.00	0.00	0.00	0.00	5.59
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	69.35	0.00	0.00	0.00	0.00	9.06
Leverage & Solvency	-	-	-	-	-	-	-	-	-
Debt to Equity	0.23	0.13	0.18	0.09	0.22	0.04	0.09	0.10	0.17
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.09	0.03	0.02	0.06	0.10
Financial Leverage	-0.26	-0.32	-0.36	-0.62	-0.47	-0.62	-0.48	-0.20	-0.21
Leverage Ratio	2.17	1.86	1.85	1.53	1.53	1.37	1.41	1.57	1.66
Compound Leverage Factor	1.85	-0.86	1.77	1.51	1.58	1.52	1.71	1.81	1.72
Debt to Total Capital	18.87%	11.33%	15.29%	8.03%	18.01%	4.13%	8.66%	9.04%	14.30%
Short-Term Debt to Total Capital	18.87%	11.33%	15.29%	8.03%	10.93%	1.42%	6.56%	3.74%	6.04%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	7.08%	2.71%	2.10%	5.30%	8.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	90.76%	0.00%	0.00%	35.13%	26.40%	16.00%	15.44%	15.59%	14.96%
Common Equity to Total Capital	-9.63%	88.66%	84.71%	56.83%	55.60%	79.87%	75.90%	75.36%	70.74%
Debt to EBITDA	1.30	5.25	1.16	0.69	2.31	0.85	1.26	0.85	1.08
Net Debt to EBITDA	-1.45	-14.24	-2.34	-5.51	-3.07	-13.90	-3.43	-1.29	-1.68
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.91	0.56	0.31	0.50	0.62
Debt to NOPAT	1.71	10.40	1.64	0.75	1.89	0.91	1.74	1.15	1.53
Net Debt to NOPAT	-1.91	-28.21	-3.30	-6.02	-2.51	-14.78	-4.72	-1.76	-2.39
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.74	0.60	0.42	0.68	0.89
Altman Z-Score	0.00	2.82	3.57	5.03	8.10	5.45	1.77	2.55	2.19
Noncontrolling Interest Sharing Ratio	111.87%	38.02%	0.00%	28.67%	34.78%	19.85%	16.80%	17.03%	17.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-
Current Ratio	2.36	2.88	2.08	3.71	2.53	4.63	2.43	2.35	2.31
Quick Ratio	1.64	2.15	1.20	1.72	1.61	3.48	1.22	1.06	1.34
Cash Flow Metrics	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-10	-1.49	4.12	-76	-55	-317	-103	94
Operating Cash Flow to CapEx	-933.25%	-1,244.39%	377.54%	968.38%	-259.97%	-438.03%	-68.27%	-121.73%	184.87%
Free Cash Flow to Firm to Interest Expense	0.00	-9.68	-2.99	5.53	-77.35	-72.21	-191.77	-38.39	22.67
Operating Cash Flow to Interest Expense	-14.03	-7.56	13.87	12.62	-13.80	-52.41	-37.58	-28.10	36.73
Operating Cash Flow Less CapEx to Interest Expense	-15.54	-8.17	10.20	11.32	-19.10	-64.37	-92.62	-51.17	16.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.65	0.87	0.67	0.56	0.37	0.34	0.41	0.47
Accounts Receivable Turnover	1.54	1.55	2.60	3.48	3.14	2.72	2.28	2.06	2.07
Inventory Turnover	1.20	1.43	1.48	1.36	1.30	0.94	0.67	0.60	0.68
Fixed Asset Turnover	12.10	15.87	24.68	29.35	26.52	23.37	8.02	3.92	3.32
Accounts Payable Turnover	1.54	1.71	1.98	2.14	2.16	1.55	1.36	1.33	1.46
Days Sales Outstanding (DSO)	237.22	235.17	140.36	104.98	116.30	133.95	159.77	177.21	176.31
Days Inventory Outstanding (DIO)	303.24	256.07	245.88	268.15	279.83	386.37	543.62	608.47	534.27
Days Payable Outstanding (DPO)	237.48	213.84	184.07	170.78	168.91	236.15	268.11	275.25	249.18
Cash Conversion Cycle (CCC)	302.98	277.41	202.17	202.34	227.22	284.17	435.28	510.43	461.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-
Invested Capital	15	26	33	47	148	241	603	786	811
Invested Capital Turnover	1.80	1.77	2.52	2.66	1.61	1.34	0.92	0.80	0.98
Increase / (Decrease) in Invested Capital	0.00	11	7.25	14	100	94	362	183	25
Enterprise Value (EV)	0.00	67	155	286	1,507	1,229	387	1,203	852
Market Capitalization	0.00	81	174	336	1,500	1,663	458	1,184	946
Book Value per Share	($1.12)	$2.60	$3.27	$5.35	$7.64	$34.66	$11.35	$12.66	$14.44
Tangible Book Value per Share	($1.13)	$2.59	$3.25	$5.33	$7.61	$34.64	$11.33	$12.62	$14.39
Total Capital	25	45	62	171	254	847	889	1,018	1,279
Total Debt	4.77	5.10	9.45	14	46	35	77	92	183
Total Long-Term Debt	0.00	0.00	0.00	0.00	18	23	19	54	106
Net Debt	-5.35	-14	-19	-110	-61	-570	-209	-140	-285
Capital Expenditures (CapEx)	0.79	0.65	1.83	0.97	5.21	9.15	91	62	82
Debt-free, Cash-free Net Working Capital (DFCFNWC)	18	29	32	41	85	166	357	509	489
Debt-free Net Working Capital (DFNWC)	28	46	59	159	185	759	626	714	919
Net Working Capital (NWC)	23	41	50	145	158	747	568	675	842
Net Nonoperating Expense (NNE)	0.41	1.36	-0.81	-1.18	2.47	-4.34	-6.25	-17	-12
Net Nonoperating Obligations (NNO)	-5.35	-14	-19	-110	-61	-570	-209	-140	-285
Total Depreciation and Amortization (D&A)	0.19	0.27	0.42	0.79	1.06	2.35	5.37	8.09	9.97
Debt-free, Cash-free Net Working Capital to Revenue	65.51%	78.10%	43.15%	37.93%	54.58%	64.07%	91.88%	91.28%	62.49%
Debt-free Net Working Capital to Revenue	102.48%	126.53%	79.49%	147.55%	118.43%	292.20%	160.97%	127.94%	117.56%
Net Working Capital to Revenue	85.05%	112.58%	66.84%	134.76%	100.72%	287.58%	145.97%	121.11%	107.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.10	($0.02)	$0.14	$0.37	$0.34	$0.65	$0.66	$1.29	$1.67
Adjusted Weighted Average Basic Shares Outstanding	6.53M	20.60M	47.37M	50.40M	54.70M	57.65M	59.24M	60.16M	62.21M
Adjusted Diluted Earnings per Share	$0.06	($0.02)	$0.12	$0.33	$0.30	$0.58	$0.59	$1.16	$1.53
Adjusted Weighted Average Diluted Shares Outstanding	11.38M	20.60M	53.74M	57.41M	63.55M	65.36M	65.34M	64.87M	66.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.37	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	38.98M	42.53M	54.41M	56.23M	58.74M	59.70M	61.10M	63.13M
Normalized Net Operating Profit after Tax (NOPAT)	2.79	0.49	5.76	12	15	39	44	80	119
Normalized NOPAT Margin	10.21%	1.34%	7.72%	11.58%	9.61%	14.85%	11.40%	14.32%	15.24%
Pre Tax Income Margin	10.89%	-0.89%	9.89%	17.61%	12.32%	16.58%	17.32%	20.84%	21.26%
Debt Service Ratios	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.66	0.65	15.51	25.75	19.07	50.56	33.60	37.52	38.57
NOPAT to Interest Expense	5.33	0.46	11.57	24.53	24.59	50.43	26.78	29.79	28.71
EBIT Less CapEx to Interest Expense	5.16	0.05	11.84	24.45	13.76	38.59	-21.44	14.44	18.70
NOPAT Less CapEx to Interest Expense	3.83	-0.15	7.90	23.23	19.28	38.47	-28.27	6.71	8.85
Payout Ratios	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	4.08%	5.26%
Augmented Payout Ratio	0.00%	0.00%	0.00%	14.53%	0.00%	0.00%	0.00%	4.08%	5.26%

This table displays calculated financial ratios and metrics derived from ACM Research's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	99.53%	14.08%	76.02%	38.49%	26.07%	56.92%	104.95%	40.05%	21.00%	31.21%
EBITDA Growth	224.01%	-30.65%	206.69%	61.38%	-10.54%	99.46%	128.10%	11.33%	29.50%	121.67%
EBIT Growth	226.69%	-34.76%	183.42%	61.04%	-12.50%	103.27%	141.01%	12.25%	30.45%	128.79%
NOPAT Growth	88.81%	-14.17%	202.97%	80.49%	42.11%	23.44%	214.07%	16.87%	23.48%	75.94%
Net Income Growth	142.83%	-23.81%	220.42%	100.60%	14.47%	64.27%	146.48%	-6.54%	24.77%	67.85%
EPS Growth	113.33%	-25.93%	210.00%	127.78%	21.88%	45.00%	136.36%	-14.63%	15.38%	62.07%
Operating Cash Flow Growth	97.54%	97.80%	-9.97%	133.81%	-17,725.00%	-4,712.17%	68.36%	442.70%	166.83%	331.00%
Free Cash Flow Firm Growth	-264.89%	-348.78%	32.57%	45.47%	25.60%	52.40%	7.97%	21.83%	47.60%	103.25%
Invested Capital Growth	153.62%	149.86%	45.90%	37.84%	48.31%	30.31%	31.36%	22.99%	20.33%	3.19%
Revenue Q/Q Growth	28.08%	-18.82%	-31.59%	94.70%	16.59%	1.04%	-10.64%	33.04%	0.74%	9.56%
EBITDA Q/Q Growth	54.51%	-64.18%	-3.75%	202.92%	-14.35%	-20.13%	10.07%	47.84%	-0.37%	36.72%
EBIT Q/Q Growth	56.88%	-66.21%	-8.01%	230.29%	-14.76%	-21.51%	9.07%	53.83%	-0.94%	37.66%
NOPAT Q/Q Growth	66.08%	-38.47%	-52.22%	269.64%	30.77%	-46.55%	21.57%	37.55%	38.16%	-23.85%
Net Income Q/Q Growth	61.67%	-47.62%	-36.80%	274.84%	-7.75%	-24.83%	-5.18%	42.13%	23.16%	1.12%
EPS Q/Q Growth	77.78%	-37.50%	-45.00%	272.73%	-4.88%	-25.64%	-10.34%	34.62%	28.57%	4.44%
Operating Cash Flow Q/Q Growth	99.70%	-697.00%	-3,726.10%	137.22%	-257.06%	-115.16%	70.94%	738.31%	-80.66%	643.68%
Free Cash Flow Firm Q/Q Growth	1.43%	-30.79%	45.90%	21.83%	-34.50%	16.33%	-4.62%	33.60%	9.85%	105.20%
Invested Capital Q/Q Growth	4.92%	26.56%	2.68%	1.09%	12.89%	11.20%	3.50%	-5.35%	10.45%	-4.63%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.34%	49.57%	53.85%	47.48%	52.51%	46.43%	51.99%	47.80%	51.40%	49.59%
EBITDA Margin	27.11%	11.96%	16.83%	26.19%	19.24%	15.21%	18.73%	20.82%	20.59%	25.69%
Operating Margin	23.66%	15.36%	11.93%	21.05%	19.68%	13.72%	16.58%	18.57%	21.66%	19.68%
EBIT Margin	25.95%	10.80%	14.52%	24.64%	18.01%	13.99%	17.08%	19.75%	19.42%	24.40%
Profit (Net Income) Margin	20.25%	13.07%	12.07%	23.24%	18.39%	13.68%	14.52%	15.51%	18.96%	17.50%
Tax Burden Percent	72.11%	84.21%	75.69%	81.48%	97.74%	74.13%	83.49%	77.08%	90.61%	69.31%
Interest Burden Percent	108.21%	143.67%	109.81%	115.77%	104.45%	131.89%	101.81%	101.89%	107.76%	103.50%
Effective Tax Rate	27.89%	15.79%	24.31%	18.52%	2.26%	25.87%	16.51%	22.92%	9.39%	30.69%
Return on Invested Capital (ROIC)	19.28%	11.91%	7.29%	14.64%	16.12%	8.17%	12.28%	14.22%	18.38%	13.36%
ROIC Less NNEP Spread (ROIC-NNEP)	16.86%	11.87%	6.53%	11.38%	16.73%	4.75%	11.71%	13.12%	19.08%	9.31%
Return on Net Nonoperating Assets (RNNOA)	-5.84%	-5.70%	-2.38%	-3.80%	-4.75%	-0.96%	-2.36%	-3.14%	-3.82%	-1.96%
Return on Equity (ROE)	13.44%	6.21%	4.91%	10.85%	11.37%	7.22%	9.93%	11.08%	14.56%	11.41%
Cash Return on Invested Capital (CROIC)	-72.80%	-75.17%	-26.40%	-19.17%	-25.90%	-14.82%	-13.94%	-6.48%	-4.77%	11.78%
Operating Return on Assets (OROA)	12.05%	3.67%	5.09%	9.51%	6.98%	5.72%	7.57%	9.18%	8.83%	11.40%
Return on Assets (ROA)	9.40%	4.44%	4.23%	8.97%	7.13%	5.60%	6.43%	7.21%	8.63%	8.18%
Return on Common Equity (ROCE)	10.79%	5.17%	4.08%	9.01%	9.45%	5.99%	8.24%	9.21%	12.09%	9.43%
Return on Equity Simple (ROE_SIMPLE)	8.55%	0.00%	9.68%	12.11%	12.03%	0.00%	13.81%	12.94%	13.00%	0.00%
Net Operating Profit after Tax (NOPAT)	23	14	6.71	25	32	17	21	29	40	30
NOPAT Margin	17.06%	12.93%	9.03%	17.15%	19.23%	10.17%	13.84%	14.31%	19.63%	13.64%
Net Nonoperating Expense Percent (NNEP)	2.42%	0.04%	0.75%	3.26%	-0.61%	3.42%	0.57%	1.10%	-0.70%	4.05%
Return On Investment Capital (ROIC_SIMPLE)	-	1.58%	-	-	-	1.70%	-	-	-	2.38%
Cost of Revenue to Revenue	50.66%	50.43%	46.15%	52.52%	47.49%	53.57%	48.01%	52.20%	48.60%	50.41%
SG&A Expenses to Revenue	4.13%	6.36%	10.45%	4.64%	7.35%	8.10%	10.38%	7.95%	8.36%	9.26%
R&D to Revenue	11.73%	16.43%	18.89%	13.88%	15.51%	19.06%	15.72%	12.83%	13.65%	12.42%
Operating Expenses to Revenue	25.68%	34.21%	41.91%	26.43%	32.83%	32.70%	35.41%	29.23%	29.73%	29.90%
Earnings before Interest and Taxes (EBIT)	35	12	11	36	30	24	26	40	40	55
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	36	13	12	38	32	26	29	42	42	57
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.15	0.68	1.01	1.13	1.49	1.54	2.22	1.72	1.43	1.05
Price to Tangible Book Value (P/TBV)	1.15	0.68	1.01	1.14	1.50	1.55	2.23	1.72	1.43	1.05
Price to Revenue (P/Rev)	1.97	1.18	1.66	1.70	2.19	2.12	2.78	2.06	1.74	1.21
Price to Earnings (P/E)	17.17	11.68	13.38	11.73	15.21	15.31	20.15	16.82	14.05	9.13
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	5.83%	8.56%	7.47%	8.53%	6.58%	6.53%	4.96%	5.95%	7.12%	10.96%
Enterprise Value to Invested Capital (EV/IC)	1.20	0.64	1.01	1.15	1.51	1.53	2.19	1.78	1.45	1.05
Enterprise Value to Revenue (EV/Rev)	1.52	0.99	1.49	1.56	2.15	2.16	2.81	1.97	1.69	1.09
Enterprise Value to EBITDA (EV/EBITDA)	8.57	6.34	7.35	7.20	11.11	11.07	14.30	10.60	8.88	5.01
Enterprise Value to EBIT (EV/EBIT)	9.25	6.95	7.89	7.73	12.03	11.96	15.40	11.37	9.51	5.32
Enterprise Value to NOPAT (EV/NOPAT)	12.23	8.73	10.97	10.50	13.83	15.06	18.91	13.84	11.55	7.15
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	48.25	5.59
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.06
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.09	0.09	0.09	0.09	0.09	0.10	0.12	0.14	0.16	0.17
Long-Term Debt to Equity	0.02	0.02	0.02	0.02	0.05	0.06	0.06	0.07	0.10	0.10
Financial Leverage	-0.35	-0.48	-0.36	-0.33	-0.28	-0.20	-0.20	-0.24	-0.20	-0.21
Leverage Ratio	1.59	1.41	1.46	1.47	1.55	1.57	1.60	1.63	1.65	1.66
Compound Leverage Factor	1.72	2.02	1.61	1.71	1.62	2.07	1.63	1.66	1.77	1.71
Debt to Total Capital	8.48%	8.66%	8.50%	8.07%	8.39%	9.04%	10.66%	12.64%	13.76%	14.30%
Short-Term Debt to Total Capital	6.26%	6.56%	6.50%	6.31%	4.24%	3.74%	5.70%	6.47%	5.20%	6.04%
Long-Term Debt to Total Capital	2.22%	2.10%	2.00%	1.75%	4.15%	5.30%	4.97%	6.18%	8.56%	8.25%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	15.50%	15.44%	15.47%	15.60%	15.55%	15.59%	15.30%	14.67%	14.59%	14.96%
Common Equity to Total Capital	76.02%	75.90%	76.03%	76.33%	76.06%	75.36%	74.03%	72.68%	71.65%	70.74%
Debt to EBITDA	1.08	1.26	0.91	0.73	0.84	0.85	0.92	1.12	1.23	1.08
Net Debt to EBITDA	-4.46	-3.43	-2.51	-2.08	-1.79	-1.29	-1.18	-1.79	-1.58	-1.68
Long-Term Debt to EBITDA	0.28	0.31	0.21	0.16	0.42	0.50	0.43	0.55	0.77	0.62
Debt to NOPAT	1.53	1.74	1.36	1.07	1.04	1.15	1.22	1.47	1.60	1.53
Net Debt to NOPAT	-6.36	-4.72	-3.74	-3.04	-2.23	-1.76	-1.56	-2.34	-2.05	-2.39
Long-Term Debt to NOPAT	0.40	0.42	0.32	0.23	0.52	0.68	0.57	0.72	1.00	0.89
Altman Z-Score	2.38	1.65	1.83	2.04	2.34	2.38	2.93	2.49	2.27	2.01
Noncontrolling Interest Sharing Ratio	19.73%	16.80%	16.76%	16.88%	16.96%	17.03%	17.03%	16.88%	16.95%	17.31%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.81	2.43	2.21	2.18	2.32	2.35	2.31	2.29	2.37	2.31
Quick Ratio	1.60	1.22	1.10	1.10	1.07	1.06	1.09	1.18	1.28	1.34
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-266	-348	-188	-147	-198	-165	-173	-115	-104	5.38
Operating Cash Flow to CapEx	-0.65%	-1.13%	-204.73%	168.43%	-63.88%	-310.78%	-37.96%	470.41%	36.62%	776.06%
Free Cash Flow to Firm to Interest Expense	-634.40	-519.68	-270.65	-226.57	-309.01	-237.41	-221.09	-123.34	-85.78	4.38
Operating Cash Flow to Interest Expense	-0.24	-1.19	-43.88	17.49	-27.85	-55.03	-12.32	66.08	9.86	72.15
Operating Cash Flow Less CapEx to Interest Expense	-36.74	-106.64	-65.31	7.10	-71.45	-72.73	-44.79	52.04	-17.07	62.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.34	0.35	0.39	0.39	0.41	0.44	0.46	0.46	0.47
Accounts Receivable Turnover	2.49	2.28	2.39	2.26	2.03	2.06	2.23	2.37	2.04	2.07
Inventory Turnover	0.79	0.67	0.58	0.61	0.59	0.60	0.61	0.65	0.65	0.68
Fixed Asset Turnover	9.82	8.02	4.06	4.26	3.85	3.92	3.45	3.58	3.31	3.32
Accounts Payable Turnover	1.55	1.36	1.30	1.45	1.35	1.33	1.43	1.54	1.40	1.46
Days Sales Outstanding (DSO)	146.53	159.77	152.74	161.18	180.03	177.21	164.03	154.29	179.17	176.31
Days Inventory Outstanding (DIO)	459.86	543.62	626.46	595.43	622.16	608.47	600.78	559.92	561.68	534.27
Days Payable Outstanding (DPO)	235.19	268.11	280.01	251.68	271.11	275.25	254.52	236.74	260.21	249.18
Cash Conversion Cycle (CCC)	371.20	435.28	499.18	504.93	531.08	510.43	510.29	477.47	480.64	461.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	477	603	619	626	707	786	813	770	850	811
Invested Capital Turnover	1.13	0.92	0.81	0.85	0.84	0.80	0.89	0.99	0.94	0.98
Increase / (Decrease) in Invested Capital	289	362	195	172	230	183	194	144	144	25
Enterprise Value (EV)	572	387	626	717	1,064	1,203	1,783	1,367	1,230	852
Market Capitalization	738	458	699	783	1,087	1,184	1,766	1,430	1,268	946
Book Value per Share	$10.85	$11.35	$11.59	$11.56	$12.15	$12.66	$12.97	$13.44	$14.22	$14.44
Tangible Book Value per Share	$10.83	$11.33	$11.57	$11.52	$12.11	$12.62	$12.93	$13.39	$14.17	$14.39
Total Capital	846	889	910	906	959	1,018	1,075	1,146	1,240	1,279
Total Debt	72	77	77	73	80	92	115	145	171	183
Total Long-Term Debt	19	19	18	16	40	54	53	71	106	106
Net Debt	-298	-209	-213	-207	-171	-140	-147	-231	-219	-285
Capital Expenditures (CapEx)	15	71	15	6.74	28	12	25	13	33	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	328	357	329	333	445	509	527	487	544	489
Debt-free Net Working Capital (DFNWC)	679	626	603	598	675	714	757	831	900	919
Net Working Capital (NWC)	626	568	544	541	634	675	696	757	835	842
Net Nonoperating Expense (NNE)	-4.26	-0.15	-2.26	-8.80	1.43	-5.97	-1.03	-2.42	1.36	-8.62
Net Nonoperating Obligations (NNO)	-298	-209	-213	-207	-171	-140	-147	-231	-219	-285
Total Depreciation and Amortization (D&A)	1.55	1.26	1.71	2.24	2.07	2.07	2.52	2.17	2.39	2.89
Debt-free, Cash-free Net Working Capital to Revenue	87.31%	91.88%	78.20%	72.30%	89.74%	91.28%	82.84%	70.16%	74.65%	62.49%
Debt-free Net Working Capital to Revenue	180.75%	160.97%	143.20%	129.64%	136.02%	127.94%	119.15%	119.83%	123.43%	117.56%
Net Working Capital to Revenue	166.65%	145.97%	129.15%	117.23%	127.83%	121.11%	109.51%	109.15%	114.58%	107.68%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.35	$0.20	$0.12	$0.45	$0.43	$0.29	$0.28	$0.39	$0.49	$0.51
Adjusted Weighted Average Basic Shares Outstanding	59.36M	59.24M	59.74M	59.90M	60.22M	60.16M	61.37M	62.18M	62.50M	62.21M
Adjusted Diluted Earnings per Share	$0.32	$0.20	$0.11	$0.41	$0.39	$0.29	$0.26	$0.35	$0.45	$0.47
Adjusted Weighted Average Diluted Shares Outstanding	65.61M	65.34M	65.06M	64.93M	65.45M	64.87M	66.24M	67.06M	66.67M	66.24M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.20	$0.00	$0.00	$0.00	$0.29	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	59.46M	59.70M	59.87M	60.02M	60.61M	61.10M	62.01M	62.47M	62.63M	63.13M
Normalized Net Operating Profit after Tax (NOPAT)	23	14	6.71	25	32	17	21	29	40	30
Normalized NOPAT Margin	17.06%	12.93%	9.03%	17.15%	19.23%	10.17%	13.84%	14.31%	19.63%	13.64%
Pre Tax Income Margin	28.08%	15.52%	15.95%	28.52%	18.81%	18.45%	17.39%	20.12%	20.92%	25.25%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	82.81	17.52	15.52	54.88	47.44	34.19	33.19	42.90	32.78	44.40
NOPAT to Interest Expense	54.45	20.98	9.65	38.20	50.66	24.86	26.90	31.09	33.14	24.83
EBIT Less CapEx to Interest Expense	46.31	-87.92	-5.92	44.50	3.84	16.48	0.73	28.85	5.85	35.10
NOPAT Less CapEx to Interest Expense	17.95	-84.46	-11.78	27.82	7.06	7.16	-5.56	17.04	6.21	15.53
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	4.08%	0.00%	0.00%	0.00%	5.26%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	4.08%	0.00%	0.00%	0.00%	5.26%

Frequently Asked Questions About ACM Research's Financials

When does ACM Research's fiscal year end?

According to the most recent income statement we have on file, ACM Research's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has ACM Research's net income changed over the last 8 years?

ACM Research's net income appears to be on an upward trend, with a most recent value of $131.27 million in 2024, rising from $2.39 million in 2016. The previous period was $96.85 million in 2023.

What is ACM Research's operating income?

ACM Research's total operating income in 2024 was $151.00 million, based on the following breakdown:

Total Gross Profit: $391.55 million
Total Operating Expenses: $240.56 million

How has ACM Research revenue changed over the last 8 years?

Over the last 8 years, ACM Research's total revenue changed from $27.37 million in 2016 to $782.12 million in 2024, a change of 2,757.5%.

How much debt does ACM Research have?

ACM Research's total liabilities were at $759.82 million at the end of 2024, a 34.5% increase from 2023, and a 3,072.8% increase since 2016.

How much cash does ACM Research have?

In the past 8 years, ACM Research's cash and equivalents has ranged from $10.12 million in 2016 to $562.55 million in 2021, and is currently $407.45 million as of their latest financial filing in 2024.

How has ACM Research's book value per share changed over the last 8 years?

Over the last 8 years, ACM Research's book value per share changed from -1.12 in 2016 to 14.44 in 2024, a change of -1,390.5%.

Remove Ads

Related Companies

This page (NASDAQ:ACMR) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ACM Research (ACMR) Financials

Frequently Asked Questions About ACM Research's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ACM Research (ACMR) Financials

Annual Income Statements for ACM Research

Quarterly Income Statements for ACM Research

Annual Cash Flow Statements for ACM Research

Quarterly Cash Flow Statements for ACM Research

Annual Balance Sheets for ACM Research

Quarterly Balance Sheets for ACM Research

Annual Metrics and Ratios for ACM Research

Quarterly Metrics and Ratios for ACM Research

Frequently Asked Questions About ACM Research's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools